Company Overview of Morphochem, Inc.
Morphochem, Inc. operates as a drug discovery company in the United States. Its drug discovery programs include EDDS technology that is for the identification of drug leads, which modulate the activity of receptors; proteomics program, which identifies ligands for receptors with using EDDS and calcium measurement technologies; and anti-infectives program that is for the discover of novel agents to combat multi-drug resistant bacteria. MorphoChem, Inc., formerly known as Small Molecule Therapeutics, Inc., was founded in 1997 and is based in Monmouth Junction, New Jersey. As of March 20, 2000, MorphoChem, Inc. is a subsidiary of MorphoChem AG.
11 Deerpark Drive
Monmouth Junction, NJ 08852
Founded in 1997
Key Executives for Morphochem, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Morphochem, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.